PhD

F. Duke Haddad is currently associate director of development, director of campaigns and director of corporate development for The Salvation Army Indiana Division in Indianapolis, Indiana. In addition, he is also president of Duke Haddad and Associates, LLC in Fishers, Indiana.     

He has been a contributing author to NonProfit PRO for the past 12 years.

He received his doctorate degree from West Virginia University with an emphasis in education administration, master's degree from Marshall University with an emphasis in public administration and a bachelor's degree from West Virginia University with an emphasis in marketing/management. He has also completed post graduate work at the University of Louisville.

As you progress in your knowledge of fundraising, the importance of the concept of blending will come into play. The idea of blending gifts needs to begin with donor research.

LIVERMORE, CA, October 29, 2009 — The Fannie and John Hertz Foundation announced today that Jay Davis, PhD, has been elected President of the Hertz Foundation. Dr. Davis, the Founding Director of the Defense Threat Reduction Agency (DTRA) and the Founding Director of the Center for Accelerator Mass Spectrometry at Lawrence Livermore National Laboratory (LLNL), currently serves on the Board of Directors of the Hertz Foundation. The Hertz Foundation, established in 1957, is one of the nation’s leading non-profit organizations focused on empowering innovative young scientists and engineers.

June 25, 2009 — As of mid-2009, The Michael J. Fox Foundation for Parkinson’s Research has already funded over $1 million in high-risk, high-reward approaches to Parkinson’s therapeutic development through its groundbreaking Rapid Response Innovation Awards. Projects include investigations of the safety and efficacy of an FDA-approved drug for kidney disease to treat Parkinson’s; characterization of a tenuous link between PD and certain strains of influenza virus; and a proof-of-principle approach to refine deep brain stimulation (DBS) into a potentially more effective symptomatic therapy.

More Blogs